Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (581-590 of 662) with videos related to

Pageof 67
Sort By:
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative GroupGregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
American Journal of Hematology|March 16, 2021
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5qVictoria Panagiota, Manja Meggendorfer, Anne Sophie Kubasch, et al.
Blood|March 14, 2012
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitorsMargaret Nieborowska-Skorska, Piotr K Kopinski, Regina Ray, et al.
International Journal of Molecular Sciences|April 30, 2020
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 PatientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
American Journal of Hematology|March 30, 2021
Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasmsKlára Obrová, Silke Grumaz, Marlene Remely, et al.
Cell Reports|October 7, 2020
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow MicroenvironmentBac Viet Le, Paulina Podszywalow-Bartnicka, Silvia Maifrede, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative GroupKarl Sotlar, Tracy I George, Philip Kluin, et al.
Journal of Hematology & Oncology|August 7, 2024
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort studyChantal Lucini, Klára Obrová, Isabella Krickl, et al.
Blood|December 24, 2023
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosisGeorg Greiner, Nadine Witzeneder, Klara Klein, et al.
Pageof 67

Showing results (581-590 of 662) with videos related to

Sort By:
Pageof 67
Future Oncology (London, England)|September 13, 2018
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registrySerena Merante, Virginia V Ferretti, Chiara Elena, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative GroupGregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
American Journal of Hematology|March 16, 2021
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5qVictoria Panagiota, Manja Meggendorfer, Anne Sophie Kubasch, et al.
Blood|March 14, 2012
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitorsMargaret Nieborowska-Skorska, Piotr K Kopinski, Regina Ray, et al.
International Journal of Molecular Sciences|April 30, 2020
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 PatientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
American Journal of Hematology|March 30, 2021
Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasmsKlára Obrová, Silke Grumaz, Marlene Remely, et al.
Cell Reports|October 7, 2020
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow MicroenvironmentBac Viet Le, Paulina Podszywalow-Bartnicka, Silvia Maifrede, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative GroupKarl Sotlar, Tracy I George, Philip Kluin, et al.
Journal of Hematology & Oncology|August 7, 2024
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort studyChantal Lucini, Klára Obrová, Isabella Krickl, et al.
Blood|December 24, 2023
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosisGeorg Greiner, Nadine Witzeneder, Klara Klein, et al.
Pageof 67